Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, May 11, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
Home
Authors
Posts by admin
admin
1872 POSTS
6 COMMENTS
Latest Pharma-News
New Phase IIIb Interim Data from the STARDUST Study Shows about Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission...
admin
-
February 17, 2020
0
Latest Pharma-News
Deciphera Pharmaceuticals Announces U.S. FDA Acceptance of NDA and Priority Review for Ripretinib in the Patients with Advanced Gastrointestinal Stromal Tumors
admin
-
February 17, 2020
0
Latest Pharma-News
U.S.FDA Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application for the Lisocabtagene Maraleucel (liso-cel) for the Adult Patients with Relapsed or Refractory Large...
admin
-
February 14, 2020
0
Latest Pharma-News
Merck’s Checkpoint Inhibitor Keytruda (pembrolizumab) Hits Another Mark in Breast Cancer
admin
-
February 14, 2020
0
Latest Pharma-News
Eli Lilly Announces Topline Results for the Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
admin
-
February 14, 2020
0
Latest Pharma-News
Novartis announces MET inhibitor capmatinib, the first potential treatment for the METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
admin
-
February 13, 2020
1
Latest Pharma-News
Bayer and Nuvisan generate new research unit in Berlin
admin
-
February 13, 2020
0
Latest Pharma-News
U.S. FDA granted fast track designation for Nanobiotix for the investigation of first-in-class nbtxr3 in head and neck cancer
admin
-
February 13, 2020
0
Latest Pharma-News
Astex Pharmaceuticals announces U.S. Food and Drug Administration (FDA) acceptance for the review of NDA for the combination oral hypomethylating agent cedazuridine and decitabine...
admin
-
February 13, 2020
0
Latest Pharma-News
U.S. FDA Acceptance of New Drug Application for FibroGen’s Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
admin
-
February 12, 2020
0
Latest Pharma-News
Fennec Pharmaceuticals Completes Rolling Submission of NDA to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to the...
admin
-
February 12, 2020
0
Latest Pharma-News
Roche provides topline results from the investigator-led Phase II/III trial with gantenerumab in exceptionally inherited form of Alzheimer’s disease
admin
-
February 12, 2020
0
1
...
137
138
139
...
156
Page 138 of 156
TOP AUTHORS
admin
1872 POSTS
6 COMMENTS
OIdMIHuOdiu
0 POSTS
0 COMMENTS
tintin
0 POSTS
0 COMMENTS
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025